Update on Barriers to Pharmacotherapy for Opioid Use Disorders

Current Psychiatry Reports
Anjalee SharmaRobert P Schwartz

Abstract

The recent heroin and prescription opioid misuse epidemic has led to a sharp increase in the number of opioid overdose deaths in the USA. Notwithstanding the availability of three FDA-approved medications (methadone, buprenorphine, and naltrexone) to treat opioid use disorder, these medications are underutilized. This paper provides an update from the recent peer-reviewed literature on barriers to the use of these medications. These barriers are interrelated and can be categorized as financial, regulatory, geographic, attitudinal, and logistic. While financial barriers are common to all three medications, other barriers are medication-specific. The adverse impact of the current opioid epidemic on public health can be reduced by increasing access to effective pharmacotherapy for opioid use disorder.

References

Sep 1, 1991·American Journal of Public Health·S R YancovitzJ W Robinson
Jan 1, 1996·Substance Use & Misuse·J R CaplehornJ G Nisbet
Oct 1, 1996·Drug and Alcohol Dependence·L GreenfieldA De Smet
May 10, 2001·American Journal of Public Health·M W LangendamE J van Ameijden
Dec 7, 2002·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Sharon StancliffErnest Drucker
Apr 6, 2004·Journal of Substance Abuse Treatment·Dennis McCartyJeff Knudsen
Jun 19, 2004·The American Journal on Addictions·Marc AuriacombeJean Tignol
Jan 4, 2006·Archives of General Psychiatry·Robert P SchwartzRobert J Battjes
Jan 15, 2008·Addiction·Amy GibsonSusannah O'Brien
Feb 23, 2008·Journal of Opioid Management·Amy E BoutwellJosiah D Rich
Jun 24, 2008·Substance Abuse Treatment, Prevention, and Policy·Lori J Ducharme, Amanda J Abraham
Jul 2, 2008·Journal of General Internal Medicine·Alexander Y WalleyDaniel P Alford
Aug 1, 2008·The Journal of Behavioral Health Services & Research·Stanley S WallackSharon Reif
Sep 5, 2008·The American Journal on Addictions·Robert P SchwartzBarry S Brown
Jul 10, 2009·The Cochrane Database of Systematic Reviews·Richard P MattickMarina Davoli
Aug 27, 2009·Journal of Psychoactive Drugs·Shannon Gwin MitchellRobert P Schwartz
Jan 24, 2012·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Peter D FriedmannUNKNOWN Mat Working Group Of CJ-Dats
Dec 12, 2012·Journal of Substance Abuse Treatment·Harlan MatusowAndrew Rosenblum
Dec 25, 2012·The American Journal of Medicine·David A FiellinRichard S Schottenfeld
Mar 2, 2013·Psychiatric Services : a Journal of the American Psychiatric Association·Katharine R LevitRita Vandivort-Warren
Mar 16, 2013·American Journal of Public Health·Robert P SchwartzJerome H Jaffe
Jun 6, 2013·Addiction·Walter LingJacqueline Fahey
Feb 7, 2014·The Cochrane Database of Systematic Reviews·Richard P MattickMarina Davoli
Mar 13, 2014·Annals of Family Medicine·Eliza HutchinsonRoger A Rosenblatt
Sep 11, 2014·Journal of Substance Abuse Treatment·Aaron D FoxChinazo O Cunningham
Sep 12, 2014·American Journal of Public Health·Jon E ZibbellColleen Flanigan
Sep 15, 2014·Journal of Substance Abuse Treatment·Bradley D SteinMark Sorbero
Jan 15, 2015·Annals of Family Medicine·Roger A RosenblattEric H Larson
Apr 18, 2015·Substance Abuse Treatment, Prevention, and Policy·Todd MolfenterSandy Starr
Jun 13, 2015·American Journal of Public Health·Christopher M JonesElinore McCance-Katz
Jun 25, 2015·Journal of Addictive Diseases·Jane Carlisle Maxwell
Aug 11, 2015·Addictive Behaviors·Stacey C SigmonRobert P Schwartz
Nov 15, 2015·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Rachel M BurnsBradley D Stein
Dec 15, 2015·Journal of Substance Abuse Treatment·Kelly Alanis-HirschDennis McCarty
Jan 1, 2016·MMWR. Morbidity and Mortality Weekly Report·Rose A RuddR Matthew Gladden

❮ Previous
Next ❯

Citations

Dec 12, 2018·Journal of Addiction Medicine·Marc FishmanUNKNOWN CLEEN-SLATE Team
Oct 3, 2019·Psychiatric Services : a Journal of the American Psychiatric Association·Courtney R YarbroughGrace Bagwell Adams
Jan 8, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Amanda J AbrahamPeter D Friedmann
Oct 28, 2019·The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association·C Holly A AndrillaDavis G Patterson
Feb 7, 2019·The Annals of Pharmacotherapy·Bennett DoughtyTracy Brooks
Aug 14, 2019·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Ajay ManhapraRobert Rosenheck
Sep 16, 2020·Substance Abuse Treatment, Prevention, and Policy·Rebecca L HaffajeeAngela J Beck
Jul 1, 2017·Therapeutic Innovation & Regulatory Science·J Rick Turner
Aug 11, 2018·Journal of Addiction Medicine·Shannon Gwin MitchellRobert P Schwartz
May 26, 2018·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Shawna D BellewWesley H Self
Mar 6, 2018·Acta Crystallographica. Section C, Structural Chemistry·Karolina de Oliveira GonçalvesFelipe T Martins
May 10, 2018·Frontiers in Psychiatry·Amie L SeverinoWendy M Walwyn
May 8, 2019·Addiction Science & Clinical Practice·Jamie CarterPaula J Lum
Aug 11, 2018·Substance Abuse Treatment, Prevention, and Policy·Barbara TempalskiSamuel R Friedman
Sep 28, 2020·The Journal of Pharmacology and Experimental Therapeutics·Carly BaehrMarco Pravetoni
Aug 28, 2018·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Joseph R SchottenfeldDaniel G Tobin
Jul 1, 2020·Journal of Addiction Medicine·M Eugenia Socías, Seonaid Nolan
Feb 26, 2021·Harm Reduction Journal·Martin BuschR Michael Krausz
Mar 13, 2021·Translational Research : the Journal of Laboratory and Clinical Medicine·Mark K GreenwaldTimothy A Roehrs
Jun 13, 2018·Drug and Alcohol Dependence·M Eugenia SocíasM-J Milloy
Jun 3, 2021·The American Journal on Addictions·Marc FishmanEdward Nunes
Jun 13, 2021·Journal of Substance Abuse Treatment·Thuy NguyenKosali Simon
Feb 13, 2020·The International Journal on Drug Policy·M Eugenia SocíasM-J Milloy
Aug 20, 2021·Psychiatric Services : a Journal of the American Psychiatric Association·Amanda J AbrahamW David Bradford
Nov 13, 2020·Journal of Addiction Medicine·Courtney D NordeckDeborah Agus

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.